TG Therapeutics Inc
NASDAQ:TGTX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Wall Street
Price Targets
TGTX Price Targets Summary
TG Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TGTX
is 45.46 USD
with a low forecast of 15.15 USD and a high forecast of 63 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TGTX's stock price target?
Price Target
45.46
USD
According to Wall Street analysts, the average 1-year price target for
TGTX
is 45.46 USD
with a low forecast of 15.15 USD and a high forecast of 63 USD.
What is TG Therapeutics Inc's Revenue forecast?
Projected CAGR
46%
The
compound annual growth rate
of TG Therapeutics Inc's revenue for the next 4 years is
46%.
What is TG Therapeutics Inc's Operating Income forecast?
Projected CAGR
98%
The
compound annual growth rate
of TG Therapeutics Inc's operating income for the next 4 years is
98%.
What is TG Therapeutics Inc's Net Income forecast?
Projected CAGR
111%
The
compound annual growth rate
of TG Therapeutics Inc's net income for the next 4 years is
111%.
